After 2 months of LDCT in mice, behavioral analyses as well as expression and modification of key AD-related targets (Aβ, tau, Csf1r, Bdnf, etc.)were assessed in the hippocampus (HIP) and prefrontal cortex (PFC). This evidence concerns the gene MAPT and Alzheimer disease.